Skip to content

Rapid Diagnosis of Patients With Chest Pain During the Covid-19 Outbreak (My-ABCDE)

Application of Rapid Risk Stratification for Patients Presenting With Chest Pain in the Emergency Department During the Covid-19 Outbreak in Shanghai, China.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05394038
Acronym
My-ABCDE
Enrollment
2218
Registered
2022-05-27
Start date
2022-05-01
Completion date
2022-05-20
Last updated
2022-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Brief summary

During the outbreak of COVID-19, among patients with chest tightness and chest pain as the main symptoms in major medical institutions in Shanghai, China, the past medical history and rapid testing were used to quickly identify the risk stratification of the patients.

Detailed description

During the outbreak of COVID-19, among patients with chest tightness and chest pain as the main symptoms in major medical institutions in Shanghai, China, the past medical history and rapid testing were used to quickly identify the risk stratification of the patients. Past medical history collection includes diabetes, hypertension, coronary atherosclerotic heart disease, percutaneous coronary stent implantation, etc. Rapid detection includes rapid myocardial markers, coagulation function, electrocardiogram, chest CT, etc. Risk stratification in the shortest possible time to reduce the time patients spend congregating in hospitals and reduce unnecessary contact to reduce the risk of Covid-19 infection.

Interventions

OTHERNone,observational study.

observational study

Sponsors

Shanghai 10th People's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All patients who came to the hospital with chest tightness and chest pain during Covid-19.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frameDescription
Diagnosis time1 weekThe time from the first medical contact to the time of diagnosis.

Secondary

MeasureTime frameDescription
Diagnostic accuracy1weekPreliminary and confirmed diagnoses were the same proportion of the total number of patients.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026